Initially, it looked like the second transplant would work. Four days after the procedure, on Oct. 16, Saani was in front of the camera again. She wore pink pajamas and looked tired, but as ...

See reviews below to learn more or submit your own review. How do I know I can trust these reviews about Gravely Riding Mowers? How do I know I can trust these reviews about Gravely Riding Mowers?

In a commendable and challenging randomised, double-blind trial conducted in 725 children with sickle cell anaemia aged 6 months to 15 years (n=724 included in analysis), the incidence of clinical ...

Buy one of 2024's best robot lawn mowers and you'll wonder how you ever lived without it. That's because unless you're tootling around a large estate on a ride-on mower pretending it's a Formula 1 ...

Our rigorous lab tests have uncovered big differences in quality across lawn mowers available on the market. In our expert buying guide, we explain which features to look out for and share our Best ...

Our experts have uncovered the best electric lawn mowers on the market right now, so you can trust that your model will be a cut above the rest. In our expert buying guide, we explain which features ...

Some types of sickle cell disease cause severe illness, while others have a mild or unapparent course. Sickle cell disease is present from birth and inherited from genes you receive from your parents.

The modular design means it can also operate as a lawn mower, a leaf blower module, or a towing robot, depending on which attachment you add on. Whatever yardcare task you're tackling, the Yarbo ...

Editas on Thursday kicked off a cost-cutting transition initiative after its hunt for a development sponsor for its sickle cell disease therapy renizgamglogene autogedtemcel turned up empty. As part ...

Hosur: A 30-year-old junior lawyer was chased and brutally attacked with a sickle in broad daylight by an advocate clerk when he stepped out of the Hosur court complex in Krishnagiri district on ...

The treatment for sickle cell disease and beta thalassemia is the first to be licensed using the gene-editing tool known as Crispr, for which its discoverers were awarded the Nobel prize in 2020.